Combinostics Partnership with ConcertAI’s TeraRecon adds AI-based Evaluations for Neurodegenerative Disease and Multiple Sclerosis to Eureka Clinical AI
CAMBRIDGE, Mass., April 27, 2023 /PRNewswire/ — The Eureka Clinical AI platform, from ConcertAI’s TeraRecon, now provides clinicians with the state-of-the-art artificial intelligence and deep learning technology necessary to bring comprehensive neuroradiology solutions to clinicians, including the addition of cMRI from Combinostics. MRI brain imaging is a critical tool in assessing patients with neurodegenerative…